Portland, OR, United States of America

Cristina Tognon

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oregon Health & Science University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cristina Tognon. Retrieved from https://idiyas.com/inventor/cristina-tognon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cristina Tognon: Innovator in Acute Myeloid Leukemia Treatments

Introduction

Cristina Tognon is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of medicine, particularly in the treatment of acute myeloid leukemia (AML). Her innovative work focuses on developing methods to treat AML in the presence of gene mutations.

Latest Patents

Cristina holds a patent for her invention titled "Treatments for mutations in acute myeloid leukemia." This patent outlines useful methods for treating AML in humans, specifically targeting cases where gene mutations are present. She has been recognized for her groundbreaking approach to this challenging medical condition.

Career Highlights

Cristina Tognon is affiliated with Oregon Health & Science University, where she conducts her research and develops her innovative treatments. Her work has garnered attention in the medical community, and she continues to push the boundaries of cancer treatment.

Collaborations

Cristina collaborates with esteemed colleagues, including Jeffrey Tyner and Brian Jay Druker. Their combined expertise enhances the research and development of effective treatments for AML.

Conclusion

Cristina Tognon's contributions to the field of acute myeloid leukemia treatment exemplify her dedication to medical innovation. Her work not only advances scientific understanding but also offers hope to patients facing this challenging disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…